Belmont, MA, United States of America

Joanna A Korecka-Roet


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Joanna A Korecka-Roet

Introduction

Joanna A Korecka-Roet is a notable inventor based in Belmont, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of Parkinson's disease. With a total of three patents to her name, her work focuses on innovative therapeutic approaches.

Latest Patents

Her latest patents include antisense compounds targeting Leucine-Rich Repeat Kinase 2 (LRRK2) for the treatment of Parkinson's disease. The present disclosure relates generally to compounds comprising oligonucleotides complementary to a LRRK2 RNA transcript. Certain such compounds are useful for hybridizing to a LRRK2 RNA transcript, including but not limited to a LRRK2 RNA transcript in a cell. In certain embodiments, such hybridization results in modulation of splicing of the LRRK2 transcript. In certain embodiments, such compounds are used to treat one or more symptoms associated with Parkinson's disease.

Career Highlights

Throughout her career, Joanna has worked with esteemed institutions such as Rosalind Franklin University of Medicine and Science and McLean Hospital Corporation. Her research has been pivotal in advancing our understanding of genetic factors in neurodegenerative diseases.

Collaborations

Some of her notable coworkers include Michelle L Hastings and Ole Isacson. Their collaborative efforts have contributed to the development of innovative solutions in the medical field.

Conclusion

Joanna A Korecka-Roet's work exemplifies the impact of innovative research on the treatment of complex diseases like Parkinson's. Her contributions continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…